Discussion in 'Rituximab: News and Research' started by fairlight, Jul 30, 2012.
Rituximab is also in clinical trials for MS to, I think. Not sure what phase, but if they found enough uses for a generic rituximab it might make it profitable for someone to go after a generic version.
Here's some info on the MS trials with Rutuximab dated July 16th, 2012.
MS Trial Alert: Drug Study at NIH Recruiting People with Secondary-Progressive MS
Unfortunately, AFAIK no one is allowed still to make generic versions of biologic medications, even when off patent in the U.S. as per the FDA. The rationale is that they are too difficult to make properly.
more here: http://www.merckmanuals.com/home/drugs/trade-name_and_generic_drugs/generic_biologic_drugs.html
But then, Europe and Mabthera might be different?
You can also try a Google Site Search
Separate names with a comma.